Technical Analysis for AGN - Allergan, Inc.

Grade Last Price % Change Price Change
grade D 223.99 -0.35% -0.78
AGN closed down 0.35 percent on Friday, August 18, 2017, on approximately normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
Track This Stock
Watchlist Portfolio
Trend Table & Recent Alerts
ADX Long-Term Intermediate-Term Short-Term
Strong Down Down Down
See historical AGN trend table...

Date Alert Name Type % Chg
Aug 17 Downside 200 DMA Break Bearish -0.35%
Aug 14 Lower Bollinger Band Walk Other -3.43%
Aug 11 Lower Bollinger Band Walk Other -3.53%
Aug 10 Lower Bollinger Band Walk Other -3.24%
Aug 9 MACD Bearish Centerline Cross Bearish -5.59%

Older signals for AGN ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio.
Basic chart:

Profile
Allergan, Inc. operates as a multi-specialty healthcare company primarily in the United States, Europe, Latin America, and the Asia Pacific. The company discovers, develops, and commercializes pharmaceutical, biological, medical device, and over-the-counter products for the ophthalmic, neurological, medical aesthetics, medical dermatological, breast aesthetics, urological, and other specialty markets. It operates in two segments, Specialty Pharmaceuticals and Medical Devices. The Specialty Pharmaceuticals segment produces a range of pharmaceutical products, including ophthalmic products for dry eye, glaucoma, inflammation, infection, allergy, and retinal disease; Botox for certain therapeutic and aesthetic indications; skin care products for acne, psoriasis, eyelash growth, and other prescription and over-the-counter skin care products; and urologics products. The Medical Devices segment offers a range of medical devices, such as breast implants for augmentation, revision, and reconstructive surgery, as well as tissue expanders; and facial aesthetics products. The company sells its products to drug wholesalers, independent and chain drug stores, pharmacies, commercial optical chains, opticians, mass merchandisers, food stores, hospitals, group purchasing organizations, integrated direct hospital networks, ambulatory surgery centers, government purchasing agencies, and medical practitioners. It focuses on eye care professionals, neurologists, physiatrists, dermatologists, plastic and reconstructive surgeons, aesthetic specialty physicians, bariatric surgeons, urologists, and general practitioners. The company has collaboration agreements with Molecular Partners AG; Spectrum Pharmaceuticals, Inc.; and Serenity Pharmaceuticals, LLC. Allergan, Inc. was founded in 1948 and is headquartered in Irvine, California.
Is AGN a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 256.0223
52 Week Low 182.8602
Average Volume 2,002,084
200-Day Moving Average 226.3604
50-Day Moving Average 241.5691
20-Day Moving Average 241.555
10-Day Moving Average 231.955
Average True Range 4.0523
ADX 33.62
+DI 12.01
-DI: 34.85
Chandelier Exit (Long, 3 ATRs) 243.8654
Chandelier Exit (Short, 3 ATRs) 235.2369
Upper Bollinger Band 262.778
Lower Bollinger Band 220.332
Percent B (%b) 0.09
Bandwidth 0.17572
MACD Line -4.9603
MACD Signal Line -2.5145
MACD Histogram -2.4458